Search Tag: Pancreatic Stone Protein
2023 20 Apr
An overview of promising biomarkers in critical care, characteristics a biomarker should have and how to ensure their usefulness in clinical practice. Introduction Precision medicine is a medical approach that tailors treatments based on individual patient characteristics and their unique response to therapies for a particular disease....Read more
2022 08 Dec
The role of point-of-care testing in the early identification and management of sepsis, the need for better markers to identify sepsis, an overview of the Pancreatic Stone Protein (PSP) and clinical evidence highlighting its effectiveness as a biomarker. Pancreatic Stone Protein Infections are a leading cause of morbidity and mortality...Read more
2022 09 Aug
BSI certification agency has granted Abionic’s abioSCOPE® device and PSP test the IVDR certification for in-vitro diagnostics. This certification complies with Europe’s new In-vitro Diagnostic Regulation (IVDR), and will be required for products sold within the EU from May 2022 onward. A transitional regulation allows established, non-IVDR-certified...Read more
2021 04 Oct
Real world evidence on the practical implementation of the Pancreatic Stone Protein (PSP) Sepsis Test On the 22nd of September, attendees tuned in to a lively discussion on sepsis chaired by Professor Pedro Póvoa, who is currently coordinator of the Intensive Care Unit (ICU) in one of the largest hospitals in Lisbon and who is no stranger to the...Read more